Silencing AXL in human colon cancer cells does not decrease proliferation. by Diana J. Uribe (2201695)

Morpholino-Mediated Increase in Soluble Flt-1 Expression Results in Decreased Ocular and Tumor Neovascularization by Leah A. Owen (178086)

PGE₂ decreases <i>Sost</i> expression. by Damian C. Genetos (325684)

FLCN-deficiency leads to decreased Rho activity in sub-confluent cells and delays in wound closure. by Doug A. Medvetz (300145)

“…<b>B)</b> Rho activity was measured using a Rhotekin binding assay at 70% confluence. The FLCN-null UOK257 cells had a 2.5-fold decrease in active Rho levels (Rho GTP) compared to the FLCN re-expressing UOK257-2 cells (n = 3, p<0.05). …”

Expression of Egln3 decreases tumor aggression, increases survival and normalizes glioma vascular architecture. by Vicki A. Sciorra (312082)

Cell density-dependent decrease of phosphorylation of Akt and S6 ribosomal protein. by Noriyuki Kawabata (3391739)

Bioavailable copper levels can be decreased in vivo by copper chelating agents. by Andrew Crowe (450839)

The I827K substitution destabilizes the 3D fold of E6AP^C-lobe (residues 761–875). by Steven A. Beasley (9099461)

“…<p>(A) The assigned ¹H-¹⁵N-HSQC spectrum of 3.5 mM human E6AP catalytic C-lobe (residues 761–875) using the one-letter amino acid code and residue number according to the human E6AP sequence. …”

5-fold validation results for model training with sex-specific data. by M. Mendez (6624953)

Decreased Aβ42 halo overlaps with the decreased incidence of DNs in FO treated mice. by Milena Jović (6707702)

“…(E-H) In the FO-treated 5xFAD animals the decreased surface of the Aβ halo overlaps with the decreased incidence of swollen, dystrophic neurites.…”

Blocking C5L2 decreased MPO concentration in the supernatant of C5a-primed neutrophils. by Jian Hao (160736)

NTCU-induced increase in K5 and K14 expressing basal cells and decrease in CCSP and ACT positive cells in the tracheal epithelium. by Moumita Ghosh (344206)

SGK1 expression is significantly decreased in the prefrontal cortex of PTSD patients. by Pawel Licznerski (82554)

“…<p>(A) Microarray gene expression analysis of postmortem dorsolateral PFC (DLPFC) samples collected from patients with PTSD shows decreased levels of SGK1 mRNA. …”

Genes and pathways decreased in 16E6/FN123 HFKs. by Justine Levan (4579156)

“…<p>(A) A subset of the over 200 genes that were decreased in 16E6/FN123 cells compared to 16E6/control. …”

MOLM14 cells incubated with Eltrombopag for 6 hours show higher expression of stress response genes. by Anna Kalota (7415)

Paclitaxel Decreases COLA2 mRNA Expression in SSc Grafts by Xialin Liu (12006)

Classification of genes whose expression was decreased after removal of SOX9. by Chun-do Oh (250561)

“…Genes whose expression was decreased by more than 6-fold by the removal of SOX9 were classified into 20 functional groups; the percentages in each group of more than five genes containing a SOX9-interaction site revealed by ChIP-Seq are underlined in red on the left: the first percentage is for mouse rib chondrocytes and the second for RCS cells. …”

Proliferation marker Ki-67 is decreased by rLOX-PP treatment. by Manish V. Bais (333481)

Predictions of random forests (RF), gradient boosting machines (GBM), and neural networks (NN) trained on 12 covariates chosen using subjective feature selection. by Dennis Ochola (11626912)

Predictions of random forests (RF), gradient boosting machines (GBM), and neural networks (NN) trained on 17 covariates selected after recursive feature selection. by Dennis Ochola (11626912)